The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with ST-segment elevation myocardial infarction treated with primary or rescue percutaneous coronary intervention

EuroIntervention 2009;5:604-609. DOI: 10.4244/EIJV5I5A97

1. Rambam Health Care Campus Cardiology Department, Haifa, Israel; 2. Toronto General Hospital Cardiology Department, Toronto, Canada

Aims: Worsening renal function in patients undergoing percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is associated with adverse clinical outcomes. W

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)